1/90
Looks like no tags are added yet.
Vancomycin MOA
Binds D-Ala-D-Ala, inhibiting bacterial cell wall synthesis
Vancomycin primary coverage/clinical uses
Gram-positive organisms, including MRSA; only for C. difficile
Vancomycin must-know adverse effects
Nephrotoxicity; infusion reaction
Bactrim (TMP-SMX) MOA
Sequential inhibition of folate synthesis: SMX -> DHPS; TMP -> DFHR
Bactrim (TMP-SMX) primary coverage/clinical uses
UTIs, susceptible community MRSA, Pneumocytosis jirovcii
Bactrim (TMP-SMX) must-know adverse effects
Hyperkalemia, bone marrow suppression, SJS/TEN
Fluoroquinolones MOA
Inhibit DNA gyrase (Topoisomerase II) and topoisomerase IV
Fluoroquinolones Primary coverage/clinical uses
Gram-negative infections; selected respiratory infections
Fluoroquinolones must-known adverse effects
Tendiopathy/rupture, peripheral neuropathy, CNS effects, QT prolongation
Aminoglycosides MOA
Irreversible bind 30S ribosome; cause mRNA misleading
Aminoglycosides primary coverage/clinical uses
Serious aerobic Gram-negative infections; synergistic use in selected infections
Aminoglycoside must-known adverse effects
Nephrotoxicity, ototoxicity, neuromuscular blockade
Tetracyclines MOA
Reversibly bind 30S ribosomes; block aminoacyl-tRNA binding
Tetracyclines Primary coverage/clinical uses
Atypicals, tick-borne infections, acne, susceptible MRSA
Tetraycycline must-know adverse effects
Photosensitivity, esophagitis, tooth discoloration
Macrolide MOA
Bind 50S ribosome; inhibit translocation
Macrolide primary coverage/clinical use
Respiratory infections, atypical pathogens pertussis
Macrolide must-know adverse effects
GI effects, QT prolongation, drug interactions
Linezolid MOA
Binds 50S ribosome; prevents initiation complex formation
Linezolid primary coverage/clinical uses
MRSA, VRE, resistant Gram-positive infections
Linzeolid must know adverse effects
Thrombocytopenia, serotonin syndrome, neuropathy
Clindamycin MOA
Binds 50S ribosome; inhibits protein synthesis
Clindamycin primary coverage/clinical uses
Anaerobes (especially above diaphragm), selected Gram-positive infections
Clindamycin must-known adverse effects
C. difficile infection, diarrhea
Vancomycin high-yield molecular/pharmaceutical property
Large, polar glycopeptide; poorly absorbed orally
Vancomycin clinical consequence
IV for system infections; oral for intestinal C. difficile
Bactrim High-yield molecular/pharmaceutical property
Two drugs inhibit consecutive steps in folate synthesis
Bactrim clinical consequence
Synergistic antibacterial action; TMP causes hyperkalemia through renal ENaC inhibition
Fluoroquinolones high-yield molecular/pharmaceutical property
Chelate polyvalent metal cations
Fluoroquinolone clinical consequence
Oral absorption decreases with calcium, magnesium, aluminum, iron
Aminoglycoside high-yield molecular pharmaceutical property
Highly polar, polycationic molecules
Aminoglycoside clinical consequence
Poor oral absorption; poor CNS penetration renal elimination
Tetracycline high-yield molecular/pharmaceutical property
Chelate polyvalent metal cations
Tetracycline clinical consequence
Absorption reduced by antacids, iron, and certain dairy products
Macrolide high-yield molecular/pharmaceutical property
Weak bases that accumulate intracellularly
Macrolide clinical consequence
Useful against intracellular pathogens; erythromycin and clarithromycin inhibit CYP3A4
Linezolid high-yield molecular/pharmacueitcal property
Also inhibts monoamine oxidase (MAO), reversibly
Linezolid clinical consequence
Risk of serotonin syndrome with serotonergic drugs
Clindamycin high-yield molecular/pharmaceutical property
Strong activity against susceptible anaerobic gut flora
Clindamycin clinical consequence
Disrupts intestinal microbiota -> increased C. difficile risk
What drug class is Ciprofloxacin in?
Fluoroquinolones
What is a distinguishing clinical pearl regarding Ciprofloxacin
Strong gram-negative activity, including Pseudomonas; weak pneumococcal coverage
What drug class is Levofloxacin
Fluoroquinolones
What is a distinguishing clinical pearl regarding levofloxacin
Respiratory fluoroquinolone; covers S. pneumoniae and Pseudomonas
What drug class is moxifloxacin
Fluoroquinolones
What is a distinguishing clinical pearl regarding Moxifloxacin
Respiratory and anaerobic activity; not appropriate for UTIs because urinary concentrations are inadequate
What drug class is Ofloxacin
Fluoroquinolones
Distinguishing clinical pearl of Ofloxacin
Older fluoroquinolone; systemic, ophthalmic, and otic formulations
What drug class is Gentamicin
Aminoglycoside
Distinguishing clinical learn of Gentamicin
Serious gram-negative infections; selected synergistic regimens
What drug class is Tobramycin
Aminoglycoside
Distinguishing clinical pearl of Tobramycin
Particularly useful against Pseudomonas; inhaled formulation for chronic pulmonary infection
What drug class is Amikacin
Aminoglycosides
Distinguishing clinical pearl regarding Amikacin
Aminoglycoside
Distinguishing clinical pearl of Amikacin
Often retains activity against some gentamicin/tobramycin-resistant organisms
What drug class is Tetracycline
Tetracyclines
Distinguishing clinical pearl regarding Tetraycycline
Greater food/cation absorption concerns; renal elimination
What drug class is doxycycline
Tetracycline
Distinguishing clinical pearl regarding doxycycline
Excellent oral bioavailability; minimal dependence on renal clearance
What drug class is Minocycline
Tetracycline
Distinguishing clinical pearl of Minocycline
More lipophilic, vestibular adverse effects and pigmentation
What drug class is Azithromycin
Macrolide
Distinguishing clinical pearl regarding azithromycin
Long tissue persistence; relatively few CYP450 interactions
What drug class is Clarithromycin
Macrolide
Distinguishing clinical pearl regarding Clarithromycin
Strong CYP3A4 inhibitor; active metabolite
What drug class is Erythromycin
Macrolide
Distinguishing clinical pearl regarding Erythromycin
Strong CYP3A4 inhibitor; pronounced GI effects from motilin receptor stimulation
What antibiotic might a patient be taking if they develop tendon pain, and why?
Fluoroquinolones-tendon toxicity, potentially rupture
What antibiotic might a patient be taking if they develop hearing loss and why?
Aminoglycosides-Can cause ototoxicity
What antibiotic might a patient be taking if they develop hyperkalemia and why?
Bactrim-Trimethoprim blocks renal ENaC
What antibiotic might a patient be taking if they develop severe diarrhea/CDAD and why?
Clindamycin-Disruption of normal intestinal microbiota
What antibiotic might a patient be taking if they develop serotonin toxicity while also taking an SSRI and why?
Linezolid-Reversible MAO inhibition
What antibiotic might a patient be taking if they develop a decreased antibiotic absorption with iron supplements and why?
Tetracyclines or fluoroquinolones-Metal-ion chelation
What antibiotic might a patient be taking if they develop photosensitivity and why?
Tetracyclines or fluoroquinolones-Drug-associated phototoxicity
What antibiotic might a patient be taking if the antibiotic produces infusion-related flushing and why?
IV Vancomycin-Rate-dependent histamine release
What antibiotic might a patient be taking if they are also taking a statin and develop interaction concerns and why?
Clarithromycin, Erythromycin-CYP3A4 inhibition (Especially with CYP3A4-substrate statins)
What antibiotic might a patient be taking if the oral antibiotic treats intestinal infection but not systemic infection and why?
Vancomycin-Negligible oral bioavailability
Is Vancomycin primarily bactericidal or bacteriostatic
Primarily bactericidal
Is Bactrim primarily bactericidal or bacteriostatic
Primarily bactericidal
Are fluoroquinolones primarily bactericidal or bacteriostatic
Primarily bactericidal
Are amonglycosides primarily bactericidal or bacteriostatic
Primarily bactericidal
Are tetracyclines primarily bactericidal or bacteriostatic
Primarily bacteriostatic
Are Macrolides primarily bactericidal or bacteriostatic
Primarily bacteriostatic
Are Macrolides primarily bactericidal or bacteriostatic
Primarily bacteriostatic
Is Linezolid primarily bactericidal or bacteriostatic
Primarily bacteriostatic
is clindamycin primarily bactericidal or bacteriostatic
Primarily bacteriostatic
Take home message for Cell wall versus DNA versus ribosomes
Know the molecular target first
Take home message for 30S versus 50S
Aminoglycosides and tetracyclines target 30S; macrolides, linezolid and clindamycin target 50S
Take home message for molecular properties dictate PK
Vancomycin and aminoglycosides are poorly absorbed orally; tetracyclines and fluoroquinolones chelate cations
Take home message for mechanisms that explain patient care
TMP causes hyperkalemia; linezolid inhibits MAO; macrolides can inhibit CYP3A4
Take home message to recognize signature toxicities
Aminoglycosides -> Ears/kidneys
Fluoroquinolones -> tendons
Clindamycin -> C. Difficile
Linezolid -> Platelets